Litcius/Paper detail

ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response

Sankari Nagarajan, Shalini V. Rao, Joseph E. Sutton, Danya Cheeseman, Shanade Dunn, Evangelia K. Papachristou, Jose-Enrique Gonzalez Prada, Dominique‐Laurent Couturier, Sanjeev Kumar, Kamal Kishore, Chandra Sekhar Reddy Chilamakuri, Silvia-Elena Glont, Emily Archer Goode, Cara Brodie, Naomi Guppy, Rachael Natrajan, Alejandra Bruna, Carlos Caldas, Alasdair Russell, Rasmus Siersbæk, Kosuke Yusa, Igor Chernukhin, Jason S. Carroll

2020Nature Genetics182 citationsDOIOpen Access PDF

Topics & Concepts

ARID1ABromodomainBiologyBRD4Cancer researchChromatinHistoneEstrogen receptor alphaChromatin remodelingHistone deacetylaseGeneticsEstrogen receptorCancerBreast cancerGeneMutationChromatin Remodeling and CancerProtein Degradation and InhibitorsCancer Mechanisms and Therapy
ARID1A influences HDAC1/BRD4 activity, intrinsic proliferative capacity and breast cancer treatment response | Litcius